BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane a2 receptors

Julien Hanson; Stéphanie Rolin; Xavier de Leval; Philippe Neven; Laurence de Leval; Bernard Masereel; Bernard Pirotte; Jean-Michel Dogné

BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane a2 receptors

Julien Hanson, Stéphanie Rolin, Xavier de Leval, Philippe Neven, Laurence de Leval, Bernard Masereel, Bernard Pirotte, Jean-Michel Dogné

Namur Research Institute for Life Sciences

Research output: Contribution to journal › Literature review

Original language	English
Journal	Blood
Volume	November suppl
Issue number	nÂ°3013
Publication status	Published - 2003

Cite this

@article{3b8007d4c02e457cbab5bb346380ae52,

title = "BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane a2 receptors",

author = "Julien Hanson and St{\'e}phanie Rolin and {de Leval}, Xavier and Philippe Neven and {de Leval}, Laurence and Bernard Masereel and Bernard Pirotte and Jean-Michel Dogn{\'e}",

year = "2003",

language = "English",

volume = "November suppl",

journal = "Blood",

publisher = "American Society of Hematology",

number = "n{\^A}°3013",

}

TY - JOUR

T1 - BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane a2 receptors

AU - Hanson, Julien

AU - Rolin, Stéphanie

AU - de Leval, Xavier

AU - Neven, Philippe

AU - de Leval, Laurence

AU - Masereel, Bernard

AU - Pirotte, Bernard

AU - Dogné, Jean-Michel

PY - 2003

Y1 - 2003

M3 - Literature review

VL - November suppl

JO - Blood

JF - Blood

IS - nÂ°3013

ER -